Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Fibrocell Science Inc.
DescriptionGene-modified autologous fibroblast that carries collagen type VII (COL7A1)
Molecular Target Collagen type VII (COL7A1)
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy
Latest Stage of DevelopmentPhase I
Standard IndicationBlistering disorder
Indication DetailsTreat recessive dystrophic epidermolysis bullosa
Regulatory Designation U.S. - Orphan Drug (Treat recessive dystrophic epidermolysis bullosa);
U.S. - Rare Pediatric Disease (Treat recessive dystrophic epidermolysis bullosa)
PartnerIntrexon Corp.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today